Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy

References

• Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell. 2021;12(5):426–17. doi:10.1007/s13238-020-00813-8.
   PubMed Web of Science ®Google Scholar
• Cogdill AP, Gaudreau PO, Arora R, Gopalakrishnan V, Wargo JA. The impact of intratumoral and gastrointestinal microbiota on systemic cancer therapy. Trends Immunol. 2018;39(11):900–920. doi:10.1016/j.it.2018.09.007.
   PubMed Web of Science ®Google Scholar
• Ferrari V, Rescigno M. The intratumoral microbiota: friend or foe? Trends Cancer. 2023;9(6):472–479. doi:10.1016/j.trecan.2023.03.005.
   PubMed Web of Science ®Google Scholar
• Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, Ge Z, Wang TC, Fox JG. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63(1):54–63. doi:10.1136/gutjnl-2013-305178.
   PubMed Web of Science ®Google Scholar
• Ling Z, Shao L, Liu X, Cheng Y, Yan C, Mei Y, Ji F, Liu X. Regulatory t cells and plasmacytoid dendritic cells within the tumor microenvironment in gastric cancer are correlated with gastric microbiota dysbiosis: A preliminary study. Front Immunol. 2019;10:533. doi:10.3389/fimmu.2019.00533.
   PubMed Web of Science ®Google Scholar
• Ahmetlić F, Riedel T, Hömberg N, Bauer V, Trautwein N, Geishauser A, Sparwasser T, Stevanović S, Röcken M, Mocikat R. Regulatory t cells in an endogenous mouse lymphoma recognize specific antigen peptides and contribute to immune escape. Cancer Immunol Res. 2019;7(4):600–608. doi:10.1158/2326-6066.Cir-18-0419.
   PubMed Web of Science ®Google Scholar
• Li Q, Wu W, Gong D, Shang R, Wang J, Yu H. Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling. Gastric Cancer. 2021;24(6):1242–1253. doi:10.1007/s10120-021-01202-8.
   PubMed Web of Science ®Google Scholar
• Hwang CH, Lee NK, Paik HD. The anti-cancer potential of heat-killed lactobacillus brevis KU15176 upon AGS cell lines through intrinsic apoptosis pathway. Int J Mol Sci. 2022;23(8):4073. doi:10.3390/ijms23084073.
   PubMed Web of Science ®Google Scholar
• Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA. 2006;103:732–737. doi:10.1073/pnas.0506655103.
   PubMed Web of Science ®Google Scholar
• Yu G, Hu N, Wang L, Wang C, Han XY, Humphry M, Ravel J, Abnet CC, Taylor PR, Goldstein AM. Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China. Int J Cancer. 2017;141(1):45–51. doi:10.1002/ijc.30700.
   PubMed Web of Science ®Google Scholar
• Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. 2014;4(1):4202. doi:10.1038/srep04202.
   PubMed Web of Science ®Google Scholar
• Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y, Liu F, Yan C, Li L, Ling Z. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine. 2019;40:336–348. doi:10.1016/j.ebiom.2018.12.034.
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–209. doi:10.1038/nature13480.
   PubMed Web of Science ®Google Scholar
• Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449–456. doi:10.1038/nm.3850.
   PubMed Web of Science ®Google Scholar
• Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, Yuan J, Chen R, Li Y, Ge Z, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012. doi:10.1038/s41467-018-03121-2.
   PubMed Web of Science ®Google Scholar
• Dai D, Yang Y, Yu J, Dang T, Qin W, Teng L, Ye J, Jiang H. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Disease. 2021;12(12):1104. doi:10.1038/s41419-021-04396-y.
   PubMed Web of Science ®Google Scholar
• Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, Wu WK, Wong SH, Chen Z, Sung JJY, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018;67(6):1024–1032. doi:10.1136/gutjnl-2017-314281.
   PubMed Web of Science ®Google Scholar
• Xia W, Liu L, Shi N, Zhang C, Tang A, He G. Epstein Barr virus infection in tree shrews alters the composition of gut microbiota and metabolome profile. Virol J. 2023;20(1):177. doi:10.1186/s12985-023-02147-3.
   PubMed Web of Science ®Google Scholar
• Neuzillet C, Marchais M, Vacher S, Hilmi M, Schnitzler A, Meseure D, Leclere R, Lecerf C, Dubot C, Jeannot E, et al. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Sci Rep. 2021;11(1):7870. doi:10.1038/s41598-021-86816-9.
   PubMed Web of Science ®Google Scholar
• Zhu G, Su H, Johnson CH, Khan SA, Kluger H, Lu L. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma. Eur J Cancer. 2021;151:25–34. doi:10.1016/j.ejca.2021.03.053.
   PubMed Web of Science ®Google Scholar
• Ma J, Gnanasekar A, Lee A, Li WT, Haas M, Wang-Rodriguez J, Chang EY, Rajasekaran M, Ongkeko WM. Influence of intratumor microbiome on clinical outcome and immune processes in prostate cancer. Cancers (Basel). 2020;12(9). doi:10.3390/cancers12092524.
   Web of Science ®Google Scholar
• Aoyama T, Yoshikawa T, Watanabe T, Hayashi T, Ogata T, Cho H, Tsuburaya A. Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. Gastric Cancer. 2011;14(3):274–278. doi:10.1007/s10120-011-0038-0.
   PubMed Web of Science ®Google Scholar
• Brandt S, Kwok T, Hartig R, König W, Backert S. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA. 2005;102(26):9300–9305. doi:10.1073/pnas.0409873102.
   PubMed Web of Science ®Google Scholar
• Yin Y, Grabowska AM, Clarke PA, Whelband E, Robinson K, Argent RH, Tobias A, Kumari R, Atherton JC, Watson SA. Helicobacter pylori potentiates epithelial: mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut. 2010;59(8):1037–1045. doi:10.1136/gut.2009.199794.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li K, Liu G, Wu R, Zhang Y, Wang S, Xu M, Lu L, Li P. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes. 2023;15(2):2249143. doi:10.1080/19490976.2023.2249143.
   PubMed Web of Science ®Google Scholar
• He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 2021;33(5):988–1000.e1007. doi:10.1016/j.cmet.2021.03.002.
   PubMed Web of Science ®Google Scholar
• Ma J, Huang L, Hu D, Zeng S, Han Y, Shen H. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor? J Exp Clin Cancer Res. 2021;40(1):327. doi:10.1186/s13046-021-02128-w.
   PubMed Web of Science ®Google Scholar
• Wan M, Ding Y, Li Z, Wang X, Xu M. Metabolic manipulation of the tumour immune microenvironment. Immunology. 2022;165(3):290–300. doi:10.1111/imm.13444.
   PubMed Web of Science ®Google Scholar
• Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity. 2014;40(6):824–832. doi:10.1016/j.immuni.2014.05.015.
   PubMed Web of Science ®Google Scholar
• Navashenaq JG, Shabgah AG, Banach M, Jamialahmadi T, Penson PE, Johnston TP, Sahebkar A. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Semin Cancer Biol. 2022;86:951–959. doi:10.1016/j.semcancer.2021.09.014.
   PubMed Web of Science ®Google Scholar
• Teng H, Wang Y, Sui X, Fan J, Li S, Lei X, Shi C, Sun W, Song M, Wang H, et al. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Cell. 2023;41(1):124–138.e126. doi:10.1016/j.ccell.2022.11.013.
   PubMed Web of Science ®Google Scholar
• Yi Y, Shen L, Shi W, Xia F, Zhang H, Wang Y, Zhang J, Wang Y, Sun X, Zhang Z, et al. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study. Clin Cancer Res. 2021;27:1329–1340. doi:10.1158/1078-0432.Ccr-20-3445.
   PubMed Web of Science ®Google Scholar
• Qiu B, Xi Y, Liu F, Li Y, Xie X, Guo J, Guo S, Wu Y, Wu L, Liang T, et al. Gut Microbiome Is Associated with the Response to Chemoradiotherapy in Patients with Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2023;115:407–418. doi:10.1016/j.ijrobp.2022.07.032.
   PubMed Web of Science ®Google Scholar
• Tang C, Yang L, Jiang X, Xu C, Wang M, Wang Q, Zhou Z, Xiang Z, Cui H. Antibiotic drug tigecycline inhibited cell proliferation and induced autophagy in gastric cancer cells. Biochem Biophys Res Commun. 2014;446(1):105–112. doi:10.1016/j.bbrc.2014.02.043.
   PubMed Web of Science ®Google Scholar
• Imai H, Saijo K, Komine K, Ueta R, Numakura R, Wakayama S, Umegaki S, Hiraide S, Kawamura Y, Kasahara Y, et al. Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study. Cancer Manag Res. 2022;14:1259–1266. doi:10.2147/cmar.S353432.
   PubMed Web of Science ®Google Scholar
• Han Z, Cheng S, Dai D, Kou Y, Zhang X, Li F, Yin X, Ji J, Zhang Z, Wang X, et al. The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer. Clin Transl Med. 2023;13(7):e1312. doi:10.1002/ctm2.1312.
   PubMed Web of Science ®Google Scholar
• Peng Z, Cheng S, Kou Y, Wang Z, Jin R, Hu H, Zhang X, Gong JF, Li J, Lu M, et al. The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer. Cancer Immunol Res. 2020;8(10):1251–1261. doi:10.1158/2326-6066.Cir-19-1014.
   PubMed Web of Science ®Google Scholar
• Xie Y, Xie F, Zhou X, Zhang L, Yang B, Huang J, Wang F, Yan H, Zeng L, Zhang L, et al. Microbiota in Tumors: From Understanding to Application. Adv Sci (Weinh). 2022;9(21):e2200470. doi:10.1002/advs.202200470.
   PubMedGoogle Scholar
• Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8(1):35. doi:10.1038/s41392-022-01304-4.
   PubMed Web of Science ®Google Scholar
• Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, Martinelli I, Menicatti M, Bartolucci G, Mandrioli J, et al. The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity? Biomedicines. 2021;9(7):753. doi:10.3390/biomedicines9070753.
   PubMed Web of Science ®Google Scholar
• Baldi S, Menicatti M, Nannini G, Niccolai E, Russo E, Ricci F, Pallecchi M, Romano F, Pedone M, Poli G, et al. Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease. Nutrients. 2021;13(3):742. doi:10.3390/nu13030742.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu Z, Horta CA, Yang J. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics. Semin Cancer Biol. 2023;88:46–66. doi:10.1016/j.semcancer.2022.12.002.
   PubMed Web of Science ®Google Scholar
• Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21(5):325–338. doi:10.1038/s41568-021-00332-6.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Huang W, Wang Y, Wang R, Yuan Y. Integration of metabolomics and transcriptomics to reveal metabolic characteristics and key targets associated with cisplatin resistance in nonsmall cell lung cancer. J Proteome Res. 2019;18(9):3259–3267. doi:10.1021/acs.jproteome.9b00209.
   PubMed Web of Science ®Google Scholar
• Zheng ZG, Xu H, Suo SS, Xu XL, Ni MW, Gu LH, Chen W, Wang LY, Zhao Y, Tian B, et al. The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer. Sci Rep. 2016;6(1):26093. doi:10.1038/srep26093.
   PubMedGoogle Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science. 2015;350(6264):1084–1089. doi:10.1126/science.aac4255.
   PubMed Web of Science ®Google Scholar
• Tintelnot J, Xu Y, Lesker TR, Schönlein M, Konczalla L, Giannou AD, Pelczar P, Kylies D, Puelles VG, Bielecka AA, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615(7950):168–174. doi:10.1038/s41586-023-05728-y.
   PubMed Web of Science ®Google Scholar
• Wang JT, Li H, Zhang H, Chen YF, Cao YF, Li RC, Lin C, Wei YC, Xiang XN, Fang HJ, et al. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer. Ann Oncol. 2019;30(2):266–273. doi:10.1093/annonc/mdy505.
   PubMed Web of Science ®Google Scholar
• van der Sluis K, van Sandick Jw, van Dieren Jm, Vollebergh MA, Grootscholten C, van den Berg Jg, Snaebjornsson P, Hartemink KJ, Veenhof A, Chalabi M, et al. The clinical impact of testing for biomarkers in gastric cancer patients: a real-world cohort. Histopathology. 2023;82(6):826–836. doi:10.1111/his.14869.
   PubMed Web of Science ®Google Scholar
• Yoon SJ, Park J, Shin Y, Choi Y, Park SW, Kang SG, Son HY, Huh YM. Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model. BMC Cancer. 2020;20(1):314. doi:10.1186/s12885-020-06814-4.
   PubMed Web of Science ®Google Scholar
• Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, Lee SH, Park JL, Park YY, Lee HS, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9(1):1777. doi:10.1038/s41467-018-04179-8.
   PubMed Web of Science ®Google Scholar
• Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol. 2012;18(39):5581–5588. doi:10.3748/wjg.v18.i39.5581.
   PubMed Web of Science ®Google Scholar
• Li Z, Gao X, Peng X, May Chen MJ, Li Z, Wei B, Wen X, Wei B, Dong Y, Bu Z, et al. Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy. Sci Adv. 2020;6(9):eaay4211. doi:10.1126/sciadv.aay4211.
   PubMed Web of Science ®Google Scholar
• Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449–1458. doi:10.1038/s41591-018-0101-z.
   PubMed Web of Science ®Google Scholar
• Lu Z, Chen H, Jiao X, Zhou W, Han W, Li S, Liu C, Gong J, Li J, Zhang X, et al. Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier. J Immunother Cancer. 2020;8(2):8. doi:10.1136/jitc-2020-000631.
   Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857. doi:10.1038/s41587-019-0209-9.
   PubMed Web of Science ®Google Scholar
• Friedman J, Alm EJ, von Mering C. Inferring correlation networks from genomic survey data. PLOS Comput Biol. 2012;8(9):e1002687. doi:10.1371/journal.pcbi.1002687.
   PubMed Web of Science ®Google Scholar
• Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–821. doi:10.1038/nbt.2676.
   PubMed Web of Science ®Google Scholar
• MJEj M. Cutadapt removes adapter sequences from high-throughput sequencing reads2011. EMBnet Journal. 2011;17(1):10–12. doi:10.14806/ej.17.1.200.
   Google Scholar
• Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–915. doi:10.1038/s41587-019-0201-4.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166–169. doi:10.1093/bioinformatics/btu638.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi:10.1093/bioinformatics/bts635.
   PubMed Web of Science ®Google Scholar
• Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman C, Fridman WH, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. doi:10.1186/s13059-016-1070-5.
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq170.
   PubMed Web of Science ®Google Scholar
• Guyon I, Weston J, Barnhill S, VJMl V. Gene selection for cancer classification using support vector machines2002. Mach Learn. 2002;46(1/3):389–422. doi:10.1023/A:1012487302797.
   Web of Science ®Google Scholar
• Hoshida Y, Brunet JP, Tamayo P, Golub TR, Mesirov JP, Hofmann O. Subclass mapping: identifying common subtypes in independent disease data sets. PLOS One. 2007;2(11):e1195. doi:10.1371/journal.pone.0001195.
   PubMed Web of Science ®Google Scholar